Ipca Laboratories Ltd.

NSE: IPCALAB | BSE: 524494 | ISIN: INE571A01038 | Industry: Pharmaceuticals
| Falling Comet
1354.4000 -7.80 (-0.57%)
NSE Jun 20, 2025 15:31 PM
Volume: 475.3K
 

1354.40
-0.57%
ICICI Securities Limited
Maintain BUY due to good traction in domestic formulations and sustainable growth amid some margin pressure in medium term Target Price and Valuation: We value Ipca at | 2490 i.e. 26x P/E on FY23E EPS...
Number of FII/FPI investors increased from 282 to 294 in Mar 2025 qtr.
More from Ipca Laboratories Ltd.
Recommended